OpenRounds Editorial
Daily Briefing
Wednesday, May 20, 2026
What Changed
Interpretable fine-tuned large language models facilitate making genetic test decisions for rare diseases (NPJ digital medicine) sets the agenda today, with PhD Student Explains Study Marking Turning Point in AI and Medicine (Harvard Medical School) reinforcing the same shift toward decisions healthcare AI leaders may need to track now [1][2].
Research
•[AI in Clinical Practice] Interpretable fine-tuned large language models facilitate making genetic test decisions for rare diseases (NPJ digital medicine) [1]. It helps operators separate early technical promise from evidence that could eventually influence workflow, validation, or procurement decisions. The evidence still needs broader validation or real-world implementation proof before it should change care delivery.
•[AI Evidence] PhD Student Explains Study Marking Turning Point in AI and Medicine (Harvard Medical School) [2]. It helps operators separate early technical promise from evidence that could eventually influence workflow, validation, or procurement decisions. The evidence still needs broader validation or real-world implementation proof before it should change care delivery.
Policy & Ops
•[AI in Clinical Practice] Extracting Social Determinants of Health From Electronic Health Records: Development and Comparison of Rule-Based and Large Language Model Methods (JMIR medical informatics) [3]. It has nearer-term implications for implementation planning, reimbursement exposure, staffing, or clinical workflow governance. Local execution details, workflow fit, and follow-through will matter more than the headline alone.
•[AI in Clinical Operations] Everyone’s Betting on AI to Solve the Physician Shortage —They’re Solving the Wrong Problem (MedCity News) [4]. It has nearer-term implications for implementation planning, reimbursement exposure, staffing, or clinical workflow governance. Local execution details, workflow fit, and follow-through will matter more than the headline alone.
•[AI in Clinical Policy] AI: As Much Peril As Promise? (KFF Health Policy) [5]. It has nearer-term implications for implementation planning, reimbursement exposure, staffing, or clinical workflow governance. Local execution details, workflow fit, and follow-through will matter more than the headline alone.
•[AI in Clinical Operations] Aetna’s chief digital and technology officer on how the insurer is using AI for patient engagement (Healthcare Dive) [6]. It has nearer-term implications for implementation planning, reimbursement exposure, staffing, or clinical workflow governance. Local execution details, workflow fit, and follow-through will matter more than the headline alone.